Elevated plasma total homocysteine and C677T mutation of the methylenetetrahydrofolate reductase gene in patients with spina bifida

QJM: An International Journal of Medicine

Volumn 90, Issue 9, 1997, Pages 593-596

  Bjorke Monsen A L ^a   Ueland, P M ^a   Schneede, J ^a   Vollset, S E ^a   Refsum, H ^a  

^a UNIVERSITY OF BERGEN   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); COBALAMIN; FOLIC ACID; HOMOCYSTEINE; METHYLMALONIC ACID;

ADOLESCENT; ARTICLE; BLOOD LEVEL; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; ERYTHROCYTE LEVEL; FOLIC ACID BLOOD LEVEL; GENE MUTATION; HUMAN; INFANT; NEWBORN; PRIORITY JOURNAL; SPINA BIFIDA;

EID: 0030886047     PISSN: 00335622     EISSN: None     Source Type: Journal    
DOI: 10.1093/qjmed/90.9.593     Document Type: Article

References (21)

1. MRC Vitamin Study Research Group. Prevention of neural tube defects - results of the Medical Research Council vitamin study. Lancet 1991; 338:131-7.
2. Czeizel AE, Dudas I. Prevention of the 1st occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med 1992; 327:1832-5.
3. Kirke PN, Molloy AM, Daly LE, Burke H, Weir DG, Scott JM. Materal plasma folate and vitamin B12 are independent risk factors for neural tube defects. Q J Med 1993; 86:703-8.
4. Steegers-Theunissen RPM, Boers GHJ, Trijbels FJM, Eskes TKAB. Neural-tube defects and derangement of homocysteine metabolism. N Engl J Med 1991; 324:199-200.
5. Mills JL, McPartlin JM, Kirke PN, Lee YJ, Conley MR, Weir DG, Scott JM. Homocysteine metabolism in pregnancies complicated by neural-tube defects. Lancet 1995; 345:149-51.
6. Kang SS, Wong PWK, Zhou J, Sora J, Lessick M, Ruggie N, Grcevich G. Thermolabile methylenetetrahydrofolate reductase in patients with coronary artery disease. Metabolism 1988; 37:611-13.
7. Kang SS, Zhou J, Wong PWK, Kowalisyn J, Strokosch G. Intermediate homocysteinemia: A thermolabile variant of methylenetetrahydrofolate reductase. Am J Hum Genet 1988; 43:414-21.
8. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GHJ, den Heijer M, Kluijtmans LAJ, van den Heuvel LP, Rozen R. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nature Genet 1995; 10:111-13.
9. Jacques PF, Bostom AG, Williams RR, Ellison RC, Eckfeldt JH, Rosenberg IH, Selhub J, Rozen R. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation 1996; 93:7-9.
10. Kluijtmans LAJ, van den Heuvel LPWJ, Boers GHJ, Frosst P, van Oost BA, den Heijer M, Stevens EMB, Trijbels JMF, Rozen R, Blom HJ. Molecular genetic analysis in mild hyperhomocysteinemia: A common mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for cardiovascular disease. Am J Hum Genet 1996; 58:35-41.
11. Guttormsen AB, Ueland PM, Nesthus I, Nygård O, Schneede J, Vollset SE, Refsum H. Determinants and vitamin responsiveness of intermediate hyperhomocysteinemia (>40 μ.mol/l). The Hordaland homocysteine study. J Clin Invest 1996; 98:2174-83.
12. van der Put NMJ, Steegers-Theunissen RPM, Frosst P, Trijbels FJM, Eskes TKAB, van den Heuvel LP, Mariman ECM, den Heyer M, Rozen R, Blom HJ. Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida. Lancet 1995; 346:1070-1.
13. Whitehead AS, Gallagher P, Mills JL, Kirke PN, Burke H, Molloy AM, Weir DG, Shields DC, Scott JM. A genetic defect in 5,10 methylenetetrahydrofolate reductase in neural tube defects. Q J Med 1995; 88:763-6.
14. Ou CY, Stevenson RE, Brown VK, Schwartz CE, Allen WP, Khoury MJ, Rozen R, Oakley GPJ, Adams MJJ. 5,10 metylenetetrahydrofolate reductase genetic polymorphism as a risk factor for neural tube defects. Am J Med Genet 1996; 63:610-14.
15. Posey DL, Khoury MJ, Mulinare J, Adams MJ, Ou CY. Is mutated MTHFR a risk factor for neural tube defects? Lancet 1996; 347:686-7.
16. Papapetrou C, Lynch SA, Burn J, Edwards YH. Methylenetetrahydrofolate reductase and neural tube defects. Lancet 1996; 348:58.
17. de Franchis R, Sebastio G, Mandato C, Andria G, Mastroiacovo P. Spina bifida, 677T→C mutation, and role of folate. Lancet 1995; 346:1703.
18. Wilcken DEL, Wang XL. Relevance to spina bifida of mutated methylenetetrahydrofolate reductase. Lancet 1996; 347:340.
19. Ulvik A, Refsum H, Kluijtmans LAJ, Ueland PM. The C677T mutation of the methylenetetrahydrofolate reductase gene determined in human blood or plasma by a method involving multiinjection capillary electrophoresis and laser-induced fluorescence detection. Clin Chem 1996; 43:2.
20. Fiskerstrand T, Refsum H, Kvalheim G, Ueland PM. Homocysteine and other thiols in plasma and urine: Automated determination and sample stability. Clin Chem 1993; 39:263-71.
21. Schneede J, Ueland PM. Application of capillary electrophoresis with laser-induced fluorescence detection for routine determination of methylmalonic acid in human serum. Anal Chem 1995; 34:812-19.